Skip to main content
Premium Trial:

Request an Annual Quote

Peter Wrighton-Smith

Inviata has appointed Peter Wrighton-Smith to its board of directors. He comes to Inviata's board with strategic product development and international commercialisation experience in addition to a broad understanding of the clinical service testing market. Wrighton-Smith is the current CEO and founder of Oxford Immunotec where he has overseen the company raise five rounds of venture funding prior to an IPO on NASDAQ in 2013.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.